Leukaemia represents one of the most challenging diagnoses in oncology nursing. When abnormal white blood cells multiply uncontrollably in the bone marrow, they crowd out healthy blood cells and compromise the body’s ability to function normally. For nurses caring for patients with leukaemia, understanding the disease process and implementing evidence-based interventions can significantly impact patient outcomes and quality of life.
Table of Contents
- Understanding leukaemia and its impact
- Recognizing the warning signs
- Diagnostic process and testing
- Treatment phases: A structured approach
- Induction therapy
- Consolidation therapy
- Maintenance therapy
- Essential nursing care priorities
- Preventing and managing infections
- Bleeding precautions
- Nutritional support and symptom management
- Emotional and psychological support
- Family education and involvement
Understanding leukaemia and its impact
Leukaemia is a cancer of the blood-forming tissues, primarily affecting the bone marrow where blood cells are produced. Unlike solid tumors, leukaemia doesn’t form a mass that can be surgically removed. Instead, abnormal cells circulate throughout the bloodstream, making systemic treatment necessary.
The disease occurs when blood cell DNA undergoes mutations, causing cells to grow and divide uncontrollably. These leukaemia cells behave like abnormal white blood cells, failing to perform their intended function of fighting infections. As they accumulate, they prevent the bone marrow from producing adequate red blood cells, normal white blood cells, and platelets.
Healthcare providers classify leukaemia into four main types based on how quickly it progresses and which cell type is affected. Acute leukaemias develop rapidly and require immediate treatment, while chronic forms progress more slowly. The classification also depends on whether the disease affects myeloid cells or lymphoid cells, leading to the four primary types: acute lymphocytic leukaemia (ALL), acute myeloid leukaemia (AML), chronic lymphocytic leukaemia (CLL), and chronic myeloid leukaemia (CML).
Recognizing the warning signs
Patients with leukaemia often present with symptoms that reflect the disease’s impact on normal blood cell production. Fatigue and weakness develop due to anemia, as the body lacks sufficient red blood cells to carry oxygen. Frequent infections signal a compromised immune system resulting from dysfunctional white blood cells.
Bleeding tendencies manifest in various ways. Patients may notice easy bruising, frequent nosebleeds, bleeding gums, or tiny red spots on the skin called petechiae. These symptoms occur because leukaemia interferes with platelet production, the cells responsible for blood clotting.
Additional warning signs include unexplained weight loss, fever, night sweats, and bone or joint pain. Some patients develop swollen lymph nodes or experience a feeling of fullness in the abdomen due to an enlarged spleen or liver. The specific symptoms often depend on the type of leukaemia and how rapidly it progresses.
Diagnostic process and testing
Diagnosing leukaemia begins with a thorough physical examination and blood work. A complete blood count typically reveals abnormal white blood cell levels, along with low red blood cell and platelet counts. However, a definitive diagnosis requires examining bone marrow.
During a bone marrow biopsy, a healthcare provider inserts a needle into the pelvic bone to extract a small sample of marrow. Laboratory analysis of this sample determines the percentage of abnormal cells present and identifies the specific type of leukaemia. Additional tests, including flow cytometry and cytogenetic analysis, help characterize the leukaemia cells and guide treatment decisions.
Imaging studies such as chest X-rays, CT scans, or MRI may be ordered to assess whether leukaemia has affected other organs or tissues. A lumbar puncture might be performed to check if leukaemia cells have spread to the cerebrospinal fluid surrounding the brain and spinal cord.
Treatment phases: A structured approach
Induction therapy
The first phase of treatment aims to achieve remission by eliminating as many leukaemia cells as possible. Induction therapy typically involves chemotherapy administered to target cancer cells in both the blood and bone marrow. This intensive phase usually lasts four to six weeks and requires close monitoring for complications.
During induction, patients often experience significant side effects as the treatment destroys not only leukaemia cells but also healthy rapidly dividing cells. The bone marrow temporarily loses its ability to produce normal blood cells, putting patients at high risk for infections, bleeding, and severe fatigue.
Consolidation therapy
Once remission is achieved, consolidation therapy begins. This phase targets any remaining undetected leukaemia cells to prevent relapse. Treatment may involve additional chemotherapy cycles, and in some cases, stem cell transplantation may be recommended for high-risk patients. Consolidation typically continues for four to six months, delivered in cycles with rest periods between treatments.
Maintenance therapy
For certain types of leukaemia, particularly acute lymphocytic leukaemia, maintenance therapy extends treatment over approximately two years. This phase uses lower-dose chemotherapy administered on an outpatient basis to eliminate any surviving leukaemia cells and maintain remission. Regular blood tests monitor the patient’s response and detect early signs of relapse.
Essential nursing care priorities
Preventing and managing infections
Infection prevention stands as the top priority when caring for leukaemia patients. Chemotherapy-induced neutropenia leaves patients extremely vulnerable to pathogens. Implementing neutropenic precautions includes strict hand hygiene, limiting visitors, and promptly reporting any signs of infection such as fever or chills.
Nurses should educate patients about avoiding potential sources of infection, including raw foods, fresh flowers, and crowded places. Regular temperature monitoring helps detect infections early, and any fever in a neutropenic patient constitutes a medical emergency requiring immediate intervention.
Bleeding precautions
Thrombocytopenia, or low platelet counts, increases bleeding risk significantly. Nurses must implement bleeding precautions by using soft toothbrushes for oral care, avoiding invasive procedures when possible, and educating patients to prevent injuries. Patients should avoid aspirin and other medications that interfere with platelet function.
Regular assessment for signs of bleeding includes checking for petechiae, bruising, bleeding gums, or blood in urine or stool. Platelet transfusions may be necessary when counts drop to critically low levels.
Nutritional support and symptom management
Maintaining adequate nutrition proves challenging for leukaemia patients experiencing nausea, mouth sores, and taste changes from chemotherapy. Nurses should encourage small, frequent meals with nutrient-dense foods. Collaborating with dietitians helps ensure patients receive appropriate nutritional support, whether through oral intake or supplemental nutrition when necessary.
Managing treatment-related side effects requires proactive intervention. Antiemetic medications prevent nausea, while good oral hygiene and gentle mouth rinses help manage mucositis. Pain management strategies should combine pharmacological interventions with comfort measures such as positioning and relaxation techniques.
Emotional and psychological support
A leukaemia diagnosis creates profound emotional distress for patients and families. Nurses play a crucial role in providing psychological support, addressing concerns, and facilitating open communication. Encouraging participation in support groups connects patients with others facing similar challenges.
Body image concerns arise from hair loss, weight changes, and other visible effects of treatment. Nurses should acknowledge these concerns and provide resources to help patients cope. Involving caregivers in education and care planning helps ensure patients receive comprehensive support at home.
Family education and involvement
Comprehensive patient and family education empowers better self-care and early recognition of complications. Nurses should explain treatment plans, potential side effects, and warning signs that require immediate medical attention. Teaching proper hand hygiene, infection prevention measures, and bleeding precautions helps families actively participate in care.
Caregivers need support managing the practical aspects of care, including transportation to appointments, medication administration, and maintaining proper nutrition. Providing written materials and demonstrating techniques ensures understanding and retention of important information.
What do you think? How might understanding the emotional impact of a leukaemia diagnosis change your approach to patient care? What strategies could you implement to better support families navigating this challenging journey?
References
- https://my.clevelandclinic.org/health/diseases/4365-leukemia
- https://www.mayoclinic.org/diseases-conditions/leukemia/symptoms-causes/syc-20374373
- https://www.webmd.com/cancer/lymphoma/understanding-leukemia-basics
- https://www.mdanderson.org/cancer-types/leukemia.html
- https://www.nurse.com/clinical-guides/leukemia/
Leave a Reply